BioXcel Therapeutics announced its CEO, Vimal Mehta, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference on August 12, 2025. The company has successfully met its Oaktree Financing Covenant by raising approximately $30.4 million through various financings, including public offerings and an at-the-market program, as of August 8, 2025. This financial achievement strengthens BioXcel’s operational stability and supports its ongoing development efforts.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.